EDIMER PHARMACEUTICALS

edimer-pharmaceuticals-logo

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers.

#SimilarOrganizations #People #Financial #Website #More

EDIMER PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2009-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.edimerpharma.com

Total Employee:
1+

Status:
Active

Contact:
(866)334-4240

Email Addresses:
Info@EdimerPharma.com

Total Funding:
40 M USD

Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright


Similar Organizations

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

david-mott_image

David Mott Board of Directors @ Edimer Pharmaceuticals
Board_member

philip-reilly_image

Philip Reilly Board Member @ Edimer Pharmaceuticals
Board_member
2009-01-01

cary-pfeffer_image

Cary Pfeffer Board Member @ Edimer Pharmaceuticals
Board_member

wendy-dixon_image

Wendy Dixon Member of the Board of Directors @ Edimer Pharmaceuticals
Board_member

Founder


neil-kirby_image

Neil Kirby

Investors List

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series B - Edimer Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Edimer Pharmaceuticals

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series B - Edimer Pharmaceuticals

vi-partners_image

VI Partners

VI Partners investment in Series B - Edimer Pharmaceuticals

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series A - Edimer Pharmaceuticals

vi-partners_image

VI Partners

VI Partners investment in Series A - Edimer Pharmaceuticals

Official Site Inspections

http://www.edimerpharma.com

  • Host name: ec2-44-213-46-149.compute-1.amazonaws.com
  • IP address: 44.213.46.149
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Edimer Pharmaceuticals"

Dimer Pharmaceuticals

Welcome to Dimer Pharmaceuticals, where we are transforming the future of cancer and neurodegenerative disease treatments. With bold innovations rooted in shared biological …See details»

Our Company — Dimer Pharmaceuticals

Welcome to Dimer Pharmaceuticals, where passion meets purpose. Our journey began with a simple yet audacious idea: What if the cure for some of the world’s most devastating diseases …See details»

Dimer Pharmaceuticals – CAC2

To transform the lives of patients by advancing innovative therapies that target MYC-driven diseases, starting with pediatric high-risk neural tumors.See details»

Our People — Dimer Pharmaceuticals

DIRECTOR, ADVOCACY AND ALLIANCES An accomplished Speech-Language Specialist with exceptional skills in communication strategy, relationship-building, and tailored interventions, …See details»

Edimer Pharmaceuticals - Crunchbase Company Profile & Funding

Jul 30, 2013 Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a …See details»

Edimer Pharmaceuticals - VentureRadar

"Edimer is a privately held biotechnology company based in Cambridge, Massachusetts dedicated to delivering a significant and durable improvement in the health and quality of life for future …See details»

Edimer Pharmaceuticals, Inc.:Company Profile & Technical …

Edimer Pharmaceuticals, Inc. is a company that provides Biology, Medicine, Ectodermal dysplasia and more. Edimer Pharmaceuticals, Inc. is headquartered in United States Massachusetts.See details»

Edimer Pharmaceuticals Company Profile | Management and

Edimer Pharmaceuticals Profile and History. Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED.See details»

Dimer Pharmaceuticals | BIO-Europe Spring

BIO-Europe Spring is the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe …See details»

Edimer Pharmaceuticals - PitchBook

Edimer Pharmaceuticals General Information Description. Developer of drugs for the treatment of X-linked hypohidrodic ectodermal dysplasia (XLHED) designed to deliver a significant and durable improvement in the health and quality of life …See details»

Edimer Pharmaceuticals Management Team | Org Chart

Search Edimer Pharmaceuticals management & employees. Enter a name to find & verify an email >>>See details»

Edimer Pharmaceuticals - Products, Competitors, Financials, …

Edimer Pharmaceuticals engages in research and development for treatments of rare dermatological diseases. Use the CB Insights Platform to explore Edimer Pharmaceuticals's …See details»

Edimer Pharmaceuticals | EquityNet

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X …See details»

Annual Report on Edimer Pharmaceuticals's Revenue, Growth, …

Trademark Applications Trademark applications show the products and services that Edimer Pharmaceuticals is developing and marketing. Edimer Pharmaceuticals doesn't have any …See details»

Our Solution — Dimer Pharmaceuticals

Dimer Pharmaceuticals is revolutionizing cancer and neurodegenerative disease treatment with its innovative “Oncodegenic Approach.” This strategy leverages the observed epidemiological …See details»

Edimer Pharma - Company Profile - Tracxn

Feb 12, 2025 Edimer Pharma - Therapeutics for rare dermatology diseases. This company is not active anymore. Raised a total funding of $40M over 2 rounds from 5 investors. Edimer …See details»

Contact — Dimer Pharmaceuticals

Info@dimerpharma.com. Name * First Name. Last Name. Email * Message * Thank you! Dimer Pharmaceuticals ...See details»

Edimer Pharmaceuticals » Triton Resources, Inc

Edimer Pharmaceuticals. Industry: Drug Discovery/Drug Development; Location: Cambridge, MA; Summary: A biotechnology company working toward improving the health and quality of life of …See details»

Edimer Pharmaceuticals - CB Insights

Explore {Edimer Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Our Science — Dimer Pharmaceuticals

At Dimer Pharmaceuticals, we are committed to tackling the most aggressive and life-threatening cancers by targeting critical drivers of disease progression. One such driver is MYCN …See details»

linkstock.net © 2022. All rights reserved